Company: BLTE
Filing Date: 2025-12-02
Form Type: 424B5
Source: 0001104659-25-117702
Chunk: 123

Company: BELITE BIO, INC
Filing Date: 2025-12-02
Form: 424B5
Chunk 123
---
 “Incorporation By Reference” of this prospectus. We urge you to read any applicable prospectus supplement and the applicable warrant agreement, in their entirety.

<div align='center'>35</div>

TABLE OF CONTENTS

### DESCRIPTION OF OVERALLOTMENT PURCHASE RIGHTS
We may issue overallotment purchase rights to purchase ADSs and/or ordinary shares and/or preferred shares and/or warrants and/or subscription rights and/or units. Overallotment purchase rights may be issued independently or together with any other securities and may be attached to, or separate from, such securities. Any overallotment purchase rights will be issued under a form of overallotment purchase right and/or overallotment purchase agreement to be filed with the SEC. The terms of any overallotment purchase rights to be issued and a description of the material provisions of the applicable form of overallotment purchase right will be set forth in the applicable prospectus supplement.

The applicable prospectus supplement relating to any overallotment purchase rights we offer, if any, will, to the extent applicable, include specific terms relating to the offering, including some or all of the following:

•

the form of such overallotment purchase rights;

•

the aggregate number of such overallotment purchase rights;

•

the price or prices at which such overallotment purchase rights will be issued and exercised;

•

the currency or currencies in which the price of such overallotment purchase rights will be payable;

•

the securities purchasable upon exercise of such overallotment purchase rights;

•

the date on which the right to exercise such overallotment purchase rights shall commence and the date on which such right shall expire;

•

if applicable, the minimum or maximum amount of such overallotment purchase rights which may be exercised at any one time;

•

if applicable, the designation and terms of the securities with which such overallotment purchase rights are issued and the number of such overallotment purchase rights issued with each such security;

•

if applicable, the date on and after which such overallotment purchase rights and the related securities will be separately transferable;

•

if applicable, any provisions for cashless exercise of the overallotment purchase rights;

•

if applicable; any exercise limitations with respect to the ownership limitations by the holder exercising the overallotment purchase rights;

•

information with respect to book-entry procedures, if any;

•

the anti-dilution provisions of the overallotment purchase rights, if any; and

•

any other terms of such warrants, including terms, procedures and limitations